BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7891114)

  • 1. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate.
    Kastin AJ; Hahn K; Zadina JE; Banks WA; Hackler L
    J Neurochem; 1995 Apr; 64(4):1855-9. PubMed ID: 7891114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
    Kastin AJ; Hahn K; Banks WA; Zadina JE
    Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extreme stability of Tyr-MIF-1 in CSF.
    Kastin AJ; Banks WA; Hahn K; Zadina JE
    Neurosci Lett; 1994 Jun; 174(1):26-8. PubMed ID: 7970149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma.
    Kastin AJ; Hahn K; Erchegyi J; Zadina JE; Hackler L; Palmgren M; Banks WA
    Biochem Pharmacol; 1994 Feb; 47(4):699-709. PubMed ID: 7907473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed degradation of Tyr-MIF-1 in neonatal rat plasma.
    Kastin AJ; Hahn K; Banks WA; Zadina JE
    Peptides; 1994; 15(8):1561-3. PubMed ID: 7700856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of binding sites for N-Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in rat brain.
    Zadina JE; Kastin AJ; Krieg EF; Coy DH
    Pharmacol Biochem Behav; 1982 Dec; 17(6):1193-8. PubMed ID: 6131435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue.
    Horvath A; Kastin AJ
    J Biol Chem; 1989 Feb; 264(4):2175-9. PubMed ID: 2563371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
    Banks WA; Kastin AJ; Ehrensing CA
    J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of a novel tetrapeptide with opiate and antiopiate activity from human brain cortex: Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1).
    Erchegyi J; Kastin AJ; Zadina JE
    Peptides; 1992; 13(4):623-31. PubMed ID: 1359507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation of a novel peptide with a unique binding profile from human brain cortex: Tyr-K-MIF-1 (Tyr-Pro-Lys-Gly-NH2).
    Hackler L; Kastin AJ; Zadina JE
    Peptides; 1994; 15(6):945-50. PubMed ID: 7991457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypophysectomy increases TYR-MIF-1-like immunoreactivity in rat plasma.
    Kastin AJ; Dickson JC
    Neuroendocrinology; 1987 Mar; 45(3):177-81. PubMed ID: 2882434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opposite direction of transport across the blood-brain barrier for Tyr-MIF-1 and MIF-1: comparison with morphine.
    Banks WA; Kastin AJ
    Peptides; 1994 Jan; 15(1):23-9. PubMed ID: 7912427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of Tyr-MIF-1 to isolated brain capillaries.
    Pretorius HT; Kastin AJ; Banks WA
    Brain Res Bull; 1986 Dec; 17(6):829-31. PubMed ID: 2879616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemorphins, cytochrophins, and human beta-casomorphins bind to antiopiate (TYR-MIE-1) as well as opiate binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Brantl V
    Life Sci; 1990; 47(8):PL25-30. PubMed ID: 1976197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake, content, regulation of plasma concentrations, and binding of Tyr-MIF-1 by the adrenals.
    Kastin AJ; Fabre L; Banks WA; Zadina JE
    Neuroendocrinology; 1993 Mar; 57(3):541-9. PubMed ID: 8100620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of hematopoietic progenitor cell growth by Tyr-MIF, an endogenous opiate modulator, and its degradation products.
    Horowitz D; Callahan JF; Pelus LM; Fukuda S; King AG
    Int Immunopharmacol; 2002 Apr; 2(5):721-30. PubMed ID: 12013510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Saturable brain-to-blood transport of endomorphins.
    Kastin AJ; Fasold MB; Smith RR; Horner KA; Zadina JE
    Exp Brain Res; 2001 Jul; 139(1):70-5. PubMed ID: 11482845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-activity relationships of analogs of the endogenous brain peptides Tyr-MIF-1 and Tyr-W-MIF-1.
    Erchegyi J; Zadina JE; Qiu XD; Kersh DC; Ge LJ; Brown MM; Kastin AJ
    Pept Res; 1993; 6(1):31-8. PubMed ID: 8094991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in human brain cortex.
    Horvath A; Kastin AJ
    Int J Pept Protein Res; 1990 Sep; 36(3):281-4. PubMed ID: 1980671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic, but not acute, administration of morphine alters antiopiate (Tyr-MIF-1) binding sites in rat brain.
    Zadina JE; Kastin AJ; Ge LJ; Gulden H; Bungart KJ
    Life Sci; 1989; 44(8):555-61. PubMed ID: 2564620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.